CardioNet, Inc. (BEAT) Reports Smaller Q4 Loss, Sales Miss

CardioNet, Inc. (NASDAQ: BEAT) reported Q4 EPS of ($0.04), $0.12 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $26.8 million versus the consensus estimate of $27.99 million.

For earnings history and earnings-related data on CardioNet, Inc. (BEAT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• AptarGroup (ATR) Tops Q1 EPS by 11c
• ResMed (RMD) Tops Q3 EPS by 20c